Posted on 8/7/18
Allena Pharmaceuticals Reports Q2 2018 Financial Results and Provides Business Update
NEWTON, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to . . .
Posted on 8/7/18
Proteon Therapeutics Announces Q2 2018 Financial Results
WALTHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with . . .
Posted on 8/7/18
Radius Health Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update
WALTHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today reported its financial results for the second quarter ended June 30, 2018 . . .
Posted on 8/7/18
Merrimack Reports Second Quarter 2018 Financial Results
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced its second quarter 2018 financial results for the period ended June . . .
Posted on 8/7/18
Melinta Therapeutics Reports Second Quarter 2018 Financial Results
NEW HAVEN, Conn., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious . . .
Posted on 8/7/18
Karyopharm Reports Second Quarter 2018 Financial Results and Highlights Recent Progress
NEWTON, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today reported financial results for the second quarter 2018 and . . .
Posted on 8/7/18
Berkshire Hathaway Earnings: 5 Important Things Investors Should Know
It may seem odd to report earnings on a Saturday, but that's exactly what Berkshire Hathaway(NYSE:BRK-A) (NYSE:BRK-B) just did. The Warren Buffett-led conglomerate regularly issues earnings . . .
Posted on 8/7/18
Berkshire Hathaway's Operating Earnings Soar 67% in the Second Quarter
Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) shareholders should be pleased with the company's earnings report for the second quarter. The Omaha-based conglomerate reported operating earnings of $6.9 billion, a . . .
Posted on 8/7/18
AMAG Pharmaceuticals Completes Divestiture of Cord Blood Registry
WALTHAM, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it has closed the previously announced divestiture of Cord Blood Registry (CBR®) . . .
Posted on 8/7/18
Vericel Reports Record Second Quarter Revenues of $19.0 Million
CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, . . .
Posted on 8/6/18
Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement
Glenmark Pharmaceuticals S.A. and Harbour BioMed announced today that they have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and . . .
Posted on 8/6/18
bluebird bio and Regeneron Announce Collaboration
CAMBRIDGE, Mass. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a collaboration to apply their respective technology platforms . . .
Posted on 8/6/18
Ironwood Pharmaceuticals Provides Second Quarter 2018 Investor Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq:IRWD), a commercial biotechnology company, today provided an update on its second quarter 2018 results and recent business activities.“Ironwood’s performance during . . .
Posted on 8/6/18
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for . . .
Posted on 8/6/18
Biogen Results: Time To Change The Paradigm In Alzheimer's Disease
SummaryThe relative lack of Apoe4 carriers in the highest dose group for BAN2401 made it appear that the drug substantially slowed down the progression of mild . . .
Posted on 8/6/18
Here's Why Acceleron Pharma Inc. Lost 10.2% in July
What happenedShares of Acceleron Pharma (NASDAQ:XLRN) lost over 10% last month, according to data provided by S&P Global Market Intelligence, but it's not nearly as bad . . .
Posted on 8/6/18
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to six new employees for an . . .
Posted on 8/6/18
EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WATERTOWN, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today reported . . .
Posted on 8/6/18
Acer Therapeutics Announces Closing of Underwritten Public Offering
NEWTON, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for . . .
Posted on 8/3/18
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on August . . .
Posted on 8/3/18
Washington Trust Supports University Orthopedics in Recent Opening of Surgery Center in East Providence, RI
EAST PROVIDENCE, R.I., Aug. 03, 2018 (GLOBE NEWSWIRE) -- University Orthopedics, a regional center for orthopedic and rehabilitation care, recently opened a new, 90,000 square-foot, state-of-the-art . . .
Posted on 8/3/18
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEWTON, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board of . . .
Posted on 8/3/18
Biogen To Buy Back $3.5B Of Stock
Biogen's (NASDAQ:BIIB) Board has authorized the repurchase of up to $3.5B of the company's common stock. There is no expiration date. All shares bought back will . . .
Posted on 8/3/18
TripAdvisor (TRIP) Q2 2018 Results - Earnings Call Transcript
TripAdvisor, Inc. (NASDAQ:TRIP) Q2 2018 Earnings Call August 2, 2018 8:30 AM ETExecutivesWill Lyons - TripAdvisor, Inc.Stephen Kaufer - TripAdvisor, Inc.Ernst J. Teunissen - TripAdvisor, Inc.AnalystsDeepak . . .
Posted on 8/3/18
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor . . .

